Aramark
ARMK
$45.26
+1.07%
ARAMARK is a global provider of food services, facilities management, and uniform and career apparel, operating primarily in the Industrials sector under Specialty Business Services. The company is a market leader in outsourced food and support services, serving a diverse client base across education, healthcare, sports and entertainment, and business dining. The current investor narrative centers on the company's post-pandemic recovery trajectory and its ability to navigate inflationary pressures while demonstrating operational efficiency and margin improvement, as evidenced by its recent stock performance and market cap of approximately $11.3 billion.…
ARMK
Aramark
$45.26
Investment Opinion: Should I buy ARMK Today?
Rating & Thesis: The synthesized recommendation is Hold. The core thesis is that while ARMK's post-pandemic recovery momentum and attractive forward P/E of 17.18x are positive, these are balanced by significant fundamental risks from thin margins and high leverage, warranting a cautious stance until earnings growth materializes more convincingly. The lack of a clear analyst target price consensus prevents a definitive upside calculation, but the narrow EPS estimate range suggests low uncertainty on near-term fundamentals.
Supporting Evidence: The Hold rating is supported by a mix of encouraging and concerning data points. On the positive side: 1) The forward P/E of 17.18x is reasonable for expected growth. 2) The stock has demonstrated strong relative strength, outperforming the S&P 500 by 12.64 percentage points over 3 months. 3) Valuation on a sales basis is low (P/S of 0.56). 4) ROE of 10.37% is acceptable. Conversely, major concerns include: 1) A dangerously low net margin of 1.76%. 2) A leveraged balance sheet (D/E of 1.82). 3) A current ratio below 1 (0.99) indicating liquidity pressure. 4) A trailing P/E of 31.53x that seems rich for the underlying profitability.
Risks & Conditions: The two biggest risks that could invalidate a neutral thesis are a failure to achieve the forecasted $3.51 EPS, leading to forward multiple expansion, and a deterioration in liquidity from the current ratio of 0.99. This Hold rating would upgrade to a Buy if the forward P/E compresses further towards 15x while growth estimates hold, or if the company demonstrates sustained margin expansion above 2% net margin. It would downgrade to a Sell if revenue growth stalls, the debt-to-equity ratio climbs above 2.0, or the stock breaks below key technical support at the $38 level (from recent price action). Based on the current data, the stock appears fairly valued to slightly overvalued relative to its own risk profile, though it may be undervalued on a sales basis compared to sector peers (data unavailable).
Sign up to view all
ARMK 12-Month Price Forecast
The outlook for ARMK is one of balanced risk-reward with a slight tilt towards caution. The base case (60% probability) of range-bound trading is most likely, as the company is expected to deliver on consensus estimates but struggle to dramatically improve its low-margin profile in the face of persistent cost pressures. The bull case depends on flawless execution and multiple expansion, which seems less probable given the stock's extended technical position. The bear case, while lower probability, carries a severe downside risk to the $33 level due to the company's financial leverage. The stance would upgrade to Bullish on clear evidence of net margin expansion above 2% and a reduction in leverage. It would downgrade to Bearish on an earnings miss or a break below the $38 support level on rising volume.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aramark's 12-month outlook, with a consensus price target around $58.84 and implied upside of +30.0% versus the current price.
Average Target
$58.84
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$36 - $59
Analyst target range
Analyst coverage for ARAMARK is limited, with only 4 analysts providing estimates, which is typical for a company of its size and can lead to higher volatility and less efficient price discovery. The consensus focuses on forward estimates, with an average EPS forecast of $3.51 and revenue of $25.73 billion, with a relatively tight range between a low EPS of $3.46 and a high of $3.58, indicating strong conviction in the near-term earnings outlook. The lack of a published average target price, buy/hold/sell distribution, or institutional ratings in the provided data prevents a calculation of implied upside/downside or a clear read on sentiment strength; the narrow EPS estimate range suggests low uncertainty among the few covering analysts regarding the company's fundamental performance.
Bulls vs Bears: ARMK Investment Factors
The evidence for ARMK presents a classic tension between momentum-driven optimism and fundamental caution. The bull case is stronger on technical and forward-looking valuation grounds, supported by a powerful price trend, relative outperformance, and a reasonable forward P/E of 17.18x based on anticipated earnings growth. However, the bear case raises critical questions about the sustainability of the rally given the company's razor-thin margins (net margin of 1.76%), high leverage (D/E of 1.82), and extended price position near 52-week highs. The single most important tension in the investment debate is whether the company can successfully execute its margin improvement and earnings growth story (to $3.51 EPS) to justify its current valuation, or if the combination of operational fragility and high financial leverage will lead to disappointment and multiple compression.
Bullish
- Strong Momentum and Relative Outperformance: ARMK has delivered a 1-year price change of +35.84%, significantly outpacing the S&P 500's +29.04% gain. This robust momentum is further evidenced by a 3-month gain of +16.78% versus the market's +4.14%, indicating strong investor conviction in the recovery story.
- Attractive Forward Valuation vs. Trailing: The stock trades at a forward P/E of 17.18x, a substantial discount to its trailing P/E of 31.53x. This forward multiple implies the market is pricing in the significant earnings growth forecasted by analysts, with an average EPS estimate of $3.51, suggesting a re-rating potential as earnings materialize.
- Low Price-to-Sales and EV-to-Sales Ratios: With a P/S ratio of 0.56 and an EV/Sales ratio of 0.97, ARMK trades at a significant discount on a sales basis. These low multiples suggest the market may be undervaluing the company's large-scale, $25.7 billion revenue base relative to its enterprise value.
- Solid Return on Equity and Capital Return: The company generates a respectable ROE of 10.37%, indicating efficient use of shareholder equity. Furthermore, the 33.95% payout ratio demonstrates a commitment to returning capital to shareholders, supported by a dividend yield of approximately 1.08%.
Bearish
- Extremely Thin Profit Margins: ARMK operates with very low margins characteristic of its industry: a gross margin of 5.78% and a net margin of 1.76%. This leaves minimal room for error and makes the business highly sensitive to cost inflation and operational inefficiencies, which can quickly erode profitability.
- High Financial Leverage and Liquidity Concern: A debt-to-equity ratio of 1.82 indicates a leveraged capital structure that amplifies risk during downturns. Compounding this, a current ratio of 0.99 suggests potential difficulty in covering short-term obligations, posing a liquidity risk if operating conditions deteriorate.
- Valuation Compression Risk After Strong Run: Trading near its 52-week high of $46.88, the stock appears extended after a +35.84% yearly gain. With a beta of 1.136, it is more volatile than the market, increasing the risk of a sharp pullback if growth expectations are not met or if sector rotation occurs.
- Limited Analyst Coverage and Earnings Uncertainty: Only 4 analysts provide estimates, which can lead to less efficient price discovery and higher volatility. While the EPS estimate range is tight ($3.46-$3.58), the low coverage means sentiment can shift dramatically on a single downgrade or earnings miss.
ARMK Technical Analysis
The stock is in a sustained uptrend, evidenced by a strong 1-year price change of +35.84%, and is currently trading near the top of its 52-week range, approximately 96% of the way from its low of $33.10 to its high of $46.88. This positioning near 52-week highs signals strong momentum but also raises questions about potential overextension. Recent momentum is robust and accelerating, with the stock posting a 1-month gain of +7.33% and a 3-month gain of +16.78%, both significantly outpacing the broader market's returns of +9.98% and +4.14% for the same periods, respectively. The stock's beta of 1.136 indicates it is approximately 14% more volatile than the S&P 500, which is a relevant consideration for risk management. Key technical support is anchored at the 52-week low of $33.10, while immediate resistance lies at the recent high of $46.88; a decisive breakout above this level would confirm the bullish trend, whereas a failure could signal a consolidation phase.
Beta
1.16
1.16x market volatility
Max Drawdown
-18.4%
Largest decline past year
52-Week Range
$34-$47
Price range past year
Annual Return
+32.3%
Cumulative gain past year
| Period | ARMK Return | S&P 500 |
|---|---|---|
| 1m | +6.4% | +10.4% |
| 3m | +16.7% | +5.5% |
| 6m | +21.1% | +8.0% |
| 1y | +32.3% | +28.4% |
| ytd | +23.7% | +6.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARMK Fundamental Analysis
Revenue growth trajectory is positive, with estimated revenue for the current period averaging $25.73 billion, indicating the company's large scale, though specific quarterly YoY growth rates are not available in the provided data. Profitability metrics show a net margin of 1.76% and a trailing EPS of $0.032, which, while positive, are relatively thin; however, the forward P/E of 17.18 suggests the market anticipates significant earnings growth. The gross margin of 5.78% and operating margin of 4.28% are characteristic of the low-margin, high-volume food service industry, and the payout ratio of 33.95% indicates a commitment to returning capital to shareholders. The balance sheet shows a debt-to-equity ratio of 1.82, indicating a leveraged capital structure that could amplify returns but also increases financial risk, while a current ratio of 0.99 suggests potential liquidity constraints in covering short-term obligations. The price-to-cash-flow ratio of 11.17 provides a view of valuation relative to cash generation, and an ROE of 10.37% reflects moderate efficiency in generating profits from shareholder equity.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARMK Overvalued?
Given the positive net income, the primary valuation metric is the P/E ratio. The stock trades at a trailing P/E of 31.53x and a forward P/E of 17.18x; the significant discount of the forward multiple implies the market is pricing in a substantial expected increase in earnings, aligning with the estimated EPS growth to $3.51. Peer comparison is limited as industry average multiples are not provided in the data; however, the price-to-sales ratio of 0.56 and EV-to-Sales of 0.97 appear low, potentially suggesting a discount if sector averages are higher, though this cannot be confirmed without benchmark data. Historical context is also unavailable due to missing historical ratios data, preventing an assessment of whether the current P/E of 31.53x is near the top or bottom of its own historical range, which would help gauge if the stock is priced for perfection or presents a value opportunity.
PE
31.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: ARMK's primary financial risk stems from its leveraged balance sheet, with a debt-to-equity ratio of 1.82, which could strain cash flow in a rising interest rate environment or during a business downturn. Operationally, the company's extremely low gross margin of 5.78% and net margin of 1.76% make it highly vulnerable to inflation in food and labor costs, which could quickly erase profits. Furthermore, a current ratio of 0.99 indicates a tight liquidity position, potentially limiting financial flexibility. Revenue, while large at an estimated $25.7 billion, is dependent on the continued post-pandemic recovery in its key end markets like education, healthcare, and entertainment.
Market & Competitive Risks: The stock faces valuation compression risk after its strong 1-year run of +35.84%, now trading at 96% of its 52-week high. With a beta of 1.136, it is more volatile than the market and susceptible to broader market pullbacks or rotations away from cyclical/recovery names. The outsourced services industry is highly competitive, with pressure on pricing and margins, and ARMK's low P/S of 0.56, while potentially a value signal, may also reflect market skepticism about its growth and profitability profile relative to peers. The limited analyst coverage (only 4 analysts) exacerbates these risks, as it can lead to sharper sentiment swings on news.
Worst-Case Scenario: The worst-case scenario involves a recessionary environment that leads to client budget cuts, contract losses, and sustained input cost inflation that the company cannot pass through due to contractual agreements. This would pressure the already thin margins, potentially pushing net income negative, while high debt servicing costs from its D/E of 1.82 strain cash flow. A liquidity crisis could be triggered if the current ratio of 0.99 fails to cover obligations. In this adverse scenario, the stock could realistically revisit its 52-week low of $33.10, representing a downside of approximately -26% from the current price of $44.95. A drawdown to this level would be consistent with its historical max drawdown of -18.37% observed in the recent data.
FAQ
The key risks are, in order of severity: 1) Operational Risk: Extremely thin profitability (net margin 1.76%) leaves no room for cost overruns or inflation, which could quickly erase earnings. 2) Financial Risk: High leverage with a debt-to-equity ratio of 1.82 increases vulnerability to rising rates and economic downturns, compounded by a tight current ratio of 0.99. 3) Valuation Risk: After a 35.84% yearly gain, the stock trades near its 52-week high, increasing the risk of a pullback if growth expectations falter. 4) Market Risk: With a beta of 1.136, ARMK is more volatile than the market and susceptible to broader sector rotations away from cyclical industrials.
The 12-month forecast is scenario-dependent. The base case (60% probability) sees the stock trading between $42 and $47, as it meets EPS estimates of ~$3.51 but struggles with margin expansion. The bull case (25% probability) targets $48 to $52, requiring earnings beats and multiple expansion on successful execution. The bear case (15% probability) warns of a decline to $33-$38 if operational pressures mount and leverage becomes a concern, potentially revisiting the 52-week low. The most likely outcome is the base case, hinging on the assumption that the company can navigate cost pressures without eroding its already slim margins.
ARMK's valuation sends mixed signals. On one hand, its forward P/E of 17.18x appears reasonable if the company delivers on its $3.51 EPS forecast, and its price-to-sales ratio of 0.56 seems low, potentially indicating undervaluation on a revenue basis. On the other hand, its trailing P/E of 31.53x is high for a company with a 1.76% net margin, suggesting the stock is priced for significant future improvement. Without direct peer averages, a definitive call is difficult, but the valuation implies the market expects successful execution of earnings growth and margin expansion. Currently, it appears fairly valued to slightly overvalued relative to its own risk profile, but possibly undervalued on an asset/sales basis.
ARMK presents a nuanced risk/reward profile. For investors with a higher risk tolerance and a belief in the continued post-pandemic recovery, the forward P/E of 17.18x based on estimated EPS of $3.51 could be attractive. The stock has strong momentum, outperforming the market significantly over 3 and 12 months. However, it is not a good buy for conservative investors due to its thin net margin of 1.76%, high debt-to-equity ratio of 1.82, and potential liquidity concerns (current ratio 0.99). It may be a suitable buy for those who can closely monitor execution risks and are prepared for volatility, but a 'Hold' stance is more appropriate for most at the current price near 52-week highs.
ARMK is more suitable for a medium- to long-term investment horizon (2+ years) rather than short-term trading. The investment thesis is based on a multi-quarter recovery and margin improvement story that needs time to unfold. Its higher beta of 1.136 and sensitivity to economic cycles make it volatile for short-term trades. The company pays a modest dividend (~1.08% yield), adding a small income component for long-term holders. Given the need to monitor execution on debt reduction and margin targets, investors should be prepared to hold through potential volatility. A minimum holding period of 12-18 months is suggested to allow the fundamental story to develop.